Immune activation in HF is widely reported[170,171], with evidence of elevated serum inflammatory markers, specifically tumor-necrosis factor-alpha (TNF-α), in chronic HF patients dating back over 30 years[172]. This evidence concerns the gene TNF and hydrops fetalis.